AMENDMENT TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTESSenior Secured Convertible Promissory Notes • October 29th, 2009 • Urigen Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Amendment is made as of the 26th day of October 2009, by and between Urigen Pharmaceuticals, Inc. a Delaware corporation with its principal place of business at 27 Maiden Lane, Suite 595, San Francisco, California 94108 (the “Company”) and Platinum-Montaur Life Sciences, LLC (the “Lender”) a Delaware limited liability company.
